Kuehn Law Encourages Investors of Inspire Medical Systems, Inc. to Contact Law Firm

New York, New York--(Newsfile Corp. - December 31, 2025) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Inspire Medical Systems, Inc. (NYSE: INSP) breached their fiduciary duties to shareholders.

According to a federal securities lawsuit, Insiders at Inspire Medical caused the company to misrepresent or fail to disclose that: (1) the Inspire V launch was going poorly due to a lack of demand caused by providers holding a significant amount of surplus inventory and adoption disincentives caused by lower physician payments; (2) the launch was facing a number of critical issues because Inspire had failed to complete prerequisite tasks necessary to support the launch; (3) Inspire had not completed training and onboarding for many treatment centers, had not received the necessary IT approvals for centers to install the crucial SleepSync program, and failed to ensure that proper claims processing systems and reimbursement codes were in place at the time of launch; and (4) as a result, positive statements concerning the Company's preparedness for the Inspire V launch, and the positive progress of that launch, were materially false or misleading.

If you currently own INSP and purchased prior to August 6, 2024 please contact Justin Kuehn, Esq. by email at [e-mail] or call [phone]. Kuehn Law pays all case costs and does not charge its investor clients. Shareholders should contact the firm immediately as there may be limited time to enforce your rights.

Why Your Participation Matters:

As a shareholder your voice matters, and by getting involved, you contribute to the integrity and fairness of the financial markets. Your investment. Your voice. Your future.™

For additional information, please visit Shareholder Derivative Litigation - Kuehn Law.

Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts:
Kuehn Law, PLLC
Justin Kuehn, Esq.
53 Hill Street, Suite 605
Southampton, NY 11968
[e-mail]
[phone]

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/279286

The Inspire Medical Systems Stock at the time of publication of the news with a raise of +0,60 % to 80,14EUR on Tradegate stock exchange (30. Dezember 2025, 22:26 Uhr).